MSR15 Psychometric Validation of the Electronic Hidradenitis Suppurativa (HS) Symptom Daily Diary (eHSSDD) and Electronic HS Symptom Questionnaire (eHSSQ) Using Data from the Phase 3 BE HEARD Trials of Bimekizumab in HS
Abstract
Authors
J.R. Ingram J. Kirby V. Ciaravino R. Rolleri I. Pansar J. Lambert E. Muller C. Pelligra